Table 2.

Comparison of the burden of fungal infections in Eastern European and Middle Asian countries: estimated number of patients with fungal diseases and rate per 100,000 population.

	Azerbaijan		Kazakhstan		Kyrgyzstan		Russian Federation		Kazakhstan		Russian Federation		Uzbekistan
	n	Rate	n	Rate	n	Rate	n	Rate	n	Rate	n	Rate	n	Rate
Oesophageal candidiasis	579	5.8	1042	5.9	294	4.9	490	5.5	490	5.5	13,727	30.1	2066	6.7
Oral candidiasis	808	8.1	4393	24.8	787	13.1	1260	14.1	1260	14.1	50,847	112	4950	16
Candidemia	499	5	765	4.3	250	4.2	371	4.2	371	4.2	2278	5	1825	5.9
Candida peritonitis	75	0.75	376	0.8	50	0.8	74	0.8	74	0.8	376	0.8
RVVC	159,489	3196	273,258	2985	175,949	5865	168,834	3794	168,834	3794	893,579	3923	513,600	3339
ABPA	4927	49.4	306	1.7	2205	36.8	6008	67.5	6008	67.5	28,447	62.4	879	2.9
SAFS	6504	65.2	422	2.4	2911	48.5	7930	89.1	7930	89.1	37,491	82.3	1147	3.7
CPA total	2307	86.8	6231	35.5	3097	51.6	4161	46.8	4161	46.8	10,054	22.1	1941	6.3
IA	693	7.0	511	2.8	292	4.9	283	3.2	283	3.2	1233	2.7	1521	4.8
Cryptococcal meningitis	5	0.05	78	0.4	25	0.4	41	0.5	41	0.5	101	0.2	65	0.2
Pneumocystis pneumonia	55	0.55	1956	11.1	101	1.7	210	2.4	210	2.4	6152	13.5	1650	5.4
Mucormycosis	20	0.2	16	0.1	unk	unk	unk	unk	unk	unk	90	0.2	27	0.1
Fungal keratitis	12	0.12	unk	unk	unk	unk	unk	unk	unk	unk	unk	unk	unk	unk
Allergic fungal sinusitis	50000	50	unk	unk	unk	unk	unk	unk	unk	unk	unk	unk	unk	unk
Total burden	225,974		999,152		300,824		3,082,907		189,662		999,152		536,978

ABPA, allergic bronchopulmonary aspergillosis; CPA, chronic pulmonary aspergillosis; IA, invasive aspergillosis; RVVC, recurrent vulvovaginal candidiasis; SAFS, severe asthma with fungal sensitization; unk, unknown.